Navco Pharmaceuticals Inc.
NAV.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -670.90K | -792.50K | -1.07M | -1.27M | 371.80K |
| Total Depreciation and Amortization | 1.50K | 27.00K | 46.50K | 54.10K | 61.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 544.90K | 303.70K | 628.90K | 628.80K | -1.28M |
| Change in Net Operating Assets | 93.10K | 420.90K | 321.00K | 397.20K | 342.80K |
| Cash from Operations | -31.70K | -41.10K | -77.70K | -186.40K | -505.60K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 49.00K | 67.70K | 45.70K | 45.70K | 18.70K |
| Total Debt Repaid | -10.00K | -13.70K | -18.60K | -19.80K | -21.70K |
| Issuance of Common Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -26.80K |
| Cash from Financing | 27.80K | 38.80K | 19.90K | 19.00K | -22.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | -- | -- | -- | -- |
| Net Change in Cash | -3.80K | -2.20K | -57.70K | -167.40K | -527.90K |